← All stocks

GENELUX Corp

GNLX Net selling

CIK 0001231457 #4219 in the set updated 17 Sep 2026

Bought (120 mo)

$1.25K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$16.76M

$113.26K on a plan · $1.03M straight out of an exercise

Sold at will

$15.62M

125 of 139 sales

Net

−$16.76M

−$15.61M against sales at will

By person

17 insiders · 149 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Szalay Aladar

10% owner

—

$11.81M (59)

−$11.81M

599,821

1.33%

$1.65M

−23.7%

Yu Yong

Chief Scientific Officer

— (1)

$3.27M (26)

−$3.27M

258,688

0.5717%

$712.19K

+65.5%

Thomas John

Director

— (1)

$454.50K (10)

−$454.50K

501,193

1.11%

$1.38M

—

Zindrick Thomas

President and CEO

— (1)

$447.12K (9)

−$447.12K

1,426,427

3.15%

$3.93M

+21,257%

Ryder Sean

General Counsel

— (1)

$332.50K (4) scheduled

−$332.50K

47,621

0.1053%

$131.11K

+2,161%

Cappello Joseph

Chief Technical Officer

—

$154.44K (10)

−$154.44K

318,480

0.7039%

$876.81K

—

Tyree James L

Director

— (1)

$131.98K (4)

−$131.98K

96,483

0.2132%

$265.63K

+5,477%

Smither John W

Director

— (1)

$53.60K (2)

−$53.60K

91,403

0.2020%

$251.64K

+10,056%

Smalling Ralph

Head of Regulatory

— (1)

$43.28K (11)

−$43.28K

67,611

0.1494%

$186.14K

+1,067%

Samuelson Doug

Vice President, Finance

—

$30.78K (1)

−$30.78K

2,303

0.0051%

$6.34K

—

Jewett Caroline

Head of Quality

—

$22.74K (2)

−$22.74K

16,174

0.0357%

$44.53K

—

Zak Lourie S.

Chief Financial Officer

— (1)

$4.92K (1)

−$4.92K

82,452

0.1822%

$227.00K

+1,152%

Zhang Qian

Associate VP, Research

$1.25K (1)

—

+$1.25K

139,533

0.3084%

$384.15K

+4.7%

Mirabelli Mary

Director

— (1)

—

$0.00

102,693

0.2270%

$282.72K

—

Pulisic Matthew

Chief Financial Officer

—

278,906

0.6164%

$767.86K

—

Groen Eric

General Counsel

—

233,957

0.5171%

$644.11K

—

Woodward Gabe

Director

—

6,984

0.0154%

$19.23K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Yu Yong

24 Oct 2023

VP, Clinical Trial Operations

Sold after exercise

5,200

$19.11

$99.35K

Yu Yong

10 Oct 2023

VP, Clinical Trial Operations

Sold after exercise

400

$22.91

$9.16K

Yu Yong

10 Oct 2023

VP, Clinical Trial Operations

Sold after exercise

4,800

$21.94

$105.30K

Yu Yong

26 Sep 2023

VP, Clinical Trial Operations

Sold after exercise

2,203

$24.46

$53.89K

Yu Yong

26 Sep 2023

VP, Clinical Trial Operations

Sold after exercise

1,114

$23.51

$26.20K

Yu Yong

26 Sep 2023

VP, Clinical Trial Operations

Sold after exercise

1,883

$22.54

$42.44K

Ryder Sean

20 Sep 2023

General Counsel

Sold after exercise

10,000

$30.00

$300.00K

Yu Yong

20 Sep 2023

VP, Clinical Trial Operations

Sold after exercise

6,000

$27.96

$167.79K

Yu Yong

15 Sep 2023

VP, Clinical Trial Operations

Sold after exercise

4,675

$22.29

$104.21K

Yu Yong

15 Sep 2023

VP, Clinical Trial Operations

Sold after exercise

5,725

$21.56

$123.42K

Show all 149 transactions →

GENELUX Corp

By person

Individual transactions

What was left out